Region Hovedstadens
- Address
- lock Available on a paid plan
Region Hovedstadens - Thromboembolism Research Center
Region Hovedstadens conducts advanced clinical research in cardiovascular medicine with a specialized focus on venous thromboembolism prevention and management. The center employs innovative cluster randomized trial methodologies to evaluate comparative safety and efficacy of anticoagulant therapies in real-world clinical settings.
- Venous thromboembolism treatment and prevention strategies
- Comparative effectiveness research of low molecular weight heparins
- Bleeding risk assessment in anticoagulated patients
The research program emphasizes patient safety outcomes through rigorous evaluation of bleeding complications and mortality rates associated with different anticoagulation regimens. By investigating the balance between therapeutic efficacy and bleeding risk in patients requiring low molecular weight heparin therapy, the center contributes vital evidence for optimizing thromboprophylaxis protocols in hospitalized patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Region Hovedstadens
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Cluster randomised trial of low molecular weight heparins - Directly through Epic | Region Hovedstaden | Phase III | Not Recruiting | — | Mar 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dalteparin Sodium | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.